Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
1-Jul-2020
Entitlement Offer Cleansing Notice
1-Jul-2020
Capital Raising - Investor Presentation
1-Jul-2020
Entitlement Offer to Fund Phase 1 Clinical Trial
30-Jun-2020
Preclinical Toxicology Studies Support Phase1 Clinical Trial
29-Jun-2020
Trading Halt
25-Jun-2020
Full Year Statutory Accounts - YE 31 March 2020
2-Jun-2020
Investor Presentation
29-May-2020
Preliminary Final Report - YE 31 March 2020
19-May-2020
FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
28-Apr-2020
Quarterly Activities Report - March 2020 Qtr
Previous
1
2
3
4
5
6
7
Next